Feng Yan

17.8k total citations · 1 hit paper
397 papers, 12.5k citations indexed

About

Feng Yan is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Feng Yan has authored 397 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Molecular Biology, 61 papers in Epidemiology and 59 papers in Surgery. Recurrent topics in Feng Yan's work include Neuroinflammation and Neurodegeneration Mechanisms (41 papers), Intracerebral and Subarachnoid Hemorrhage Research (31 papers) and Helicobacter pylori-related gastroenterology studies (30 papers). Feng Yan is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (41 papers), Intracerebral and Subarachnoid Hemorrhage Research (31 papers) and Helicobacter pylori-related gastroenterology studies (30 papers). Feng Yan collaborates with scholars based in China, United States and United Kingdom. Feng Yan's co-authors include Xunming Ji, Gao Chen, Jianru Li, Lin Wang, James G. Fox, Amit Roy, Yumin Luo, Jingyin Chen, Chi Gu and Zhongming Ge and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Feng Yan

378 papers receiving 12.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of stroke in China, 2013–2019: A population-based study

2022 119 citations Feng Yan et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Feng Yan	4.4k	1.7k	1.7k	1.6k	1.6k	397	12.5k
Ping Li	6.0k 1.4×	1.2k 0.7×	1.1k 0.7×	1.5k 1.0×	849 0.5×	626	13.5k
Qian Li	6.3k 1.4×	1.0k 0.6×	675 0.4×	1.8k 1.1×	2.4k 1.5×	461	13.9k
Sung Soo Kim	6.8k 1.6×	1.4k 0.8×	1.7k 1.0×	1.7k 1.0×	667 0.4×	542	14.6k
Ying Wang	6.8k 1.5×	1.3k 0.7×	911 0.5×	2.3k 1.4×	989 0.6×	658	14.8k
Xiaoping Miao	4.7k 1.1×	2.7k 1.6×	1.7k 1.0×	2.2k 1.4×	568 0.4×	313	15.3k
Marcel Leist	10.1k 2.3×	1.5k 0.9×	808 0.5×	1.3k 0.8×	1.4k 0.9×	291	19.4k
Xiaokun Li	10.1k 2.3×	1.1k 0.6×	2.2k 1.3×	1.4k 0.9×	667 0.4×	559	21.2k
Yang Yang	9.7k 2.2×	1.7k 1.0×	1.8k 1.1×	2.9k 1.8×	1.2k 0.8×	595	19.4k
Tian Li	4.7k 1.1×	1.3k 0.7×	829 0.5×	1.6k 1.0×	707 0.4×	480	10.8k
Yun Zhang	5.5k 1.2×	963 0.6×	2.2k 1.3×	1.4k 0.9×	494 0.3×	572	14.5k

Countries citing papers authored by Feng Yan

Since Specialization

Citations

This map shows the geographic impact of Feng Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Yan more than expected).

Fields of papers citing papers by Feng Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Yan. The network helps show where Feng Yan may publish in the future.

Co-authorship network of co-authors of Feng Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Yan. A scholar is included among the top collaborators of Feng Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Yan. Feng Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yan, Feng, Iván González, & Dongwei Zhang. (2025). 1426 Tucatinib (HER2 Tyrosine Kinase Inhibitor)-Induced Liver Injury. Laboratory Investigation. 105(3). 103665–103665.

Wang, Yuan, Deng Pan, Xin Liu, et al.. (2025). USP3 promotes clear cell renal cell carcinoma progression by stabilizing MYC and enhancing glycolysis. Biochimica et Biophysica Acta (BBA) - General Subjects. 1869(6). 130801–130801. 1 indexed citations

Huang, Yuyou, Ziping Han, Tong Shen, et al.. (2024). Neutrophil migration participates in the side effect of recombinant human tissue plasminogen activator. CNS Neuroscience & Therapeutics. 30(7). e14825–e14825. 4 indexed citations

Qiao, Han, Feng Yan, Xiaolei Han, & Huaping Tang. (2024). Values of a novel comprehensive prognostic nutritional index (FIDA) in the prognosis of non-small cell lung cancer. Frontiers in Oncology. 14. 1393684–1393684.

Cao, Yu, Minghui Chen, Shuijie Li, et al.. (2024). Neutrophil extracellular traps mediate the crosstalk between plaque microenvironment and unstable carotid plaque formation. Experimental & Molecular Medicine. 56(8). 1717–1735. 10 indexed citations

Zhao, Lu, Qi Qiu, Shaowei Zhang, Feng Yan, & Xia Li. (2024). Tau pathology mediated the plasma biomarkers and cognitive function in patients with mild cognitive impairment. Experimental Gerontology. 195. 112535–112535. 1 indexed citations

Wang, Rongliang, Yuyou Huang, Yue Hu, et al.. (2024). Erythropoietin‐derived peptide ARA290 mediates brain tissue protection through the β‐common receptor in mice with cerebral ischemic stroke. CNS Neuroscience & Therapeutics. 30(3). e14676–e14676. 6 indexed citations

Sangro, Bruno, Thomas Yau, Masatoshi Kudo, et al.. (2023). Exposure‐response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040). Clinical and Translational Science. 16(8). 1445–1457. 8 indexed citations

Wen, Ning, et al.. (2023). Develop and Evaluate a Dose Calculation Strategy Using Electron Density Maps from Spectral CT. International Journal of Radiation Oncology*Biology*Physics. 117(2). e737–e737.

10.

Kang, Yoon‐Koo, Martin Reck, Paul Nghiem, et al.. (2022). Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials. Journal for ImmunoTherapy of Cancer. 10(4). e004273–e004273. 10 indexed citations

11.

Wu, Di, Jian Chen, Longfei Wu, et al.. (2022). A clinically relevant model of focal embolic cerebral ischemia by thrombus and thrombolysis in rhesus monkeys. Nature Protocols. 17(9). 2054–2084. 16 indexed citations

12.

Zhou, Hang, Jianru Li, Xiongjie Fu, et al.. (2022). Soluble Trem2 is a negative regulator of erythrophagocytosis after intracerebral hemorrhage in a CD36 receptor recycling manner. Journal of Advanced Research. 44. 185–199. 19 indexed citations

13.

Chen, Huaijun, Xiaobo Yu, Yucong Peng, et al.. (2021). Activation of Nurr1 with Amodiaquine Protected Neuron and Alleviated Neuroinflammation after Subarachnoid Hemorrhage in Rats. Oxidative Medicine and Cellular Longevity. 2021(1). 7 indexed citations

14.

Cai, Gang, Lu Cao, Youlia Kirova, Feng Yan, & Jiayi Chen. (2019). Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer. Radiation Oncology. 14(1). 115–115. 4 indexed citations

15.

Yan, Feng, Xiaoning Wang, Gaurav Bajaj, et al.. (2017). Nivolumab Exposure–Response Analyses of Efficacy and Safety in Previously Treated Squamous or Nonsquamous Non–Small Cell Lung Cancer. Clinical Cancer Research. 23(18). 5394–5405. 82 indexed citations

16.

Xu, Hangzhe, Zhijiang Wang, Jianru Li, et al.. (2017). The Polarization States of Microglia in TBI: A New Paradigm for Pharmacological Intervention. Neural Plasticity. 2017. 1–11. 100 indexed citations

17.

Yan, Feng, et al.. (2016). Exploration of Chinese style management for stroke prevention and treatment. SHILAP Revista de lepidopterología.

18.

Lu, Wei, Feng Yan, Jianming Wang, & Limei Zhu. (2016). Evaluation of MTBDRplusand MTBDRslin Detecting Drug-Resistant Tuberculosis in a Chinese Population. Disease Markers. 2016. 1–9. 9 indexed citations

19.

Yan, Feng, Amit Roy, Eric Masson, et al.. (2013). Exposure–Response Relationships of the Efficacy and Safety of Ipilimumab in Patients with Advanced Melanoma. Clinical Cancer Research. 19(14). 3977–3986. 145 indexed citations

20.

Yan, Feng, Bruce G. Pollock, Kim C. Coley, et al.. (2008). Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study. British Journal of Clinical Pharmacology. 66(5). 629–639. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact